To confirm the underlying mechanism of GL-V9 against PF in vivo, we used lysophosphatidic acid (LPA) acts as an endogenous agonist for RhoA (Fig. 6A), which plays a crucial role in fibrosis by promoting fibroblast activation and extracellular matrix remodeling [44]. The gene discussed is RHOA; the disease is pemphigus foliaceus.